Home  »  Stock   »  Novavax Inc. (NVAX): Is this the Most Sought-After...

Novavax Inc. (NVAX): Is this the Most Sought-After Stock Today?

Let’s start up with the current stock price of Novavax Inc. (NVAX), which is $11.83 to be very precise. The Stock rose vividly during the last session to $11.89 after opening rate of $11.748 while the lowest price it went was recorded $11.37 before closing at $11.55.Recently in News on January 18, 2023, Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster. Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that partner SK bioscience has received expanded manufacturing and marketing approval from the Korean Ministry of Food and Drug Safety (KMFDS) for Nuvaxovid™ (NVX-CoV2373) for use as a booster for active immunization to prevent COVID-19 in adults aged 18 and older. Prior to the approval, in September 2022, the Korean Centers for Disease Control and Prevention set out recommendations that advised that Nuvaxovid could be used as a booster in adults aged 18 and older. You can read further details here

Novavax Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $13.70 on 01/18/23, with the lowest value was $9.71 for the same time period, recorded on 01/03/23.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Novavax Inc. (NVAX) full year performance was -88.27%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Novavax Inc. shares are logging -88.33% during the 52-week period from high price, and 35.20% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $8.75 and $101.39.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 3701980 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Novavax Inc. (NVAX) recorded performance in the market was 12.35%, having the revenues showcasing -35.58% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 987.41M, as it employees total of 1541 workers.

The Analysts eye on Novavax Inc. (NVAX)

During the last month, 3 analysts gave the Novavax Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 1 analysts were recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 1 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 19.08, with a change in the price was noted -24.43. In a similar fashion, Novavax Inc. posted a movement of -67.36% for the period of last 100 days, recording 6,022,062 in trading volumes.

Technical rundown of Novavax Inc. (NVAX)

Raw Stochastic average of Novavax Inc. in the period of last 50 days is set at 18.27%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 62.42%. In the last 20 days, the company’s Stochastic %K was 58.99% and its Stochastic %D was recorded 65.03%.

Considering, the past performance of Novavax Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 12.35%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -80.41%, alongside a downfall of -88.27% for the period of the last 12 months. The shares increased approximately by -2.12% in the 7-day charts and went down by 11.92% in the period of the last 30 days. Common stock shares were lifted by -35.58% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts